Surprisingly, the CXCL9/10-binding chemokine receptor CXCR3 was specifically expressed in a small subset of breast cancer cells, exhibited tumor-initiating capacity when co-transplanted with fibroblasts, and had high JNK signaling Drives IL-1α/β expression. This evidence concerns the gene CXCL9 and breast cancer.